Titan Medical Inc. (TMD.TO)
CAD 1.13
(2150.0%)
CAD 1.13
(2150.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.97 Million USD | -61.32% |
| 2022 | 10.28 Million USD | -13.8% |
| 2021 | 11.92 Million USD | -72.67% |
| 2020 | 43.64 Million USD | 189.76% |
| 2019 | 15.06 Million USD | -14.89% |
| 2018 | 17.69 Million USD | -11.81% |
| 2017 | 20.06 Million USD | 204.15% |
| 2016 | 6.59 Million USD | -50.38% |
| 2015 | 13.29 Million USD | 130.69% |
| 2014 | 5.76 Million USD | 386.32% |
| 2013 | 1.18 Million USD | 7.33% |
| 2012 | 1.1 Million USD | -43.83% |
| 2011 | 1.96 Million USD | 170.2% |
| 2010 | 727.59 Thousand USD | 145.67% |
| 2009 | 296.17 Thousand USD | 110.3% |
| 2008 | 140.83 Thousand USD | 814.57% |
| 2007 | 15.39 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.78 Million USD | -36.75% |
| 2024 Q1 | 2.82 Million USD | -29.04% |
| 2023 Q1 | 10.17 Million USD | -1.06% |
| 2023 Q4 | 3.97 Million USD | 31.86% |
| 2023 Q3 | 3.01 Million USD | -40.76% |
| 2023 Q2 | 5.09 Million USD | -49.96% |
| 2023 FY | 3.97 Million USD | -61.32% |
| 2022 Q2 | 9.68 Million USD | 9.23% |
| 2022 Q3 | 11.11 Million USD | 14.82% |
| 2022 Q4 | 10.28 Million USD | -7.49% |
| 2022 FY | 10.28 Million USD | -13.8% |
| 2022 Q1 | 8.86 Million USD | -25.7% |
| 2021 Q3 | 24.63 Million USD | -12.44% |
| 2021 Q4 | 11.92 Million USD | -51.58% |
| 2021 FY | 11.92 Million USD | -72.67% |
| 2021 Q2 | 28.13 Million USD | -4.95% |
| 2021 Q1 | 29.6 Million USD | -32.18% |
| 2020 Q1 | 12.58 Million USD | -16.47% |
| 2020 FY | 43.64 Million USD | 189.76% |
| 2020 Q4 | 43.64 Million USD | 78.43% |
| 2020 Q3 | 24.46 Million USD | -19.17% |
| 2020 Q2 | 30.26 Million USD | 140.5% |
| 2019 Q2 | 39.53 Million USD | -1.82% |
| 2019 Q4 | 15.06 Million USD | -33.41% |
| 2019 Q1 | 40.27 Million USD | 127.54% |
| 2019 FY | 15.06 Million USD | -14.89% |
| 2019 Q3 | 22.62 Million USD | -42.79% |
| 2018 Q1 | 16.57 Million USD | -17.39% |
| 2018 FY | 17.69 Million USD | -11.81% |
| 2018 Q4 | 17.69 Million USD | -23.68% |
| 2018 Q3 | 23.18 Million USD | 13.49% |
| 2018 Q2 | 20.43 Million USD | 23.25% |
| 2017 FY | 20.06 Million USD | 204.15% |
| 2017 Q4 | 20.06 Million USD | 47.54% |
| 2017 Q2 | 9.7 Million USD | 16.52% |
| 2017 Q1 | 8.32 Million USD | 26.24% |
| 2017 Q3 | 13.6 Million USD | 40.15% |
| 2016 FY | 6.59 Million USD | -50.38% |
| 2016 Q3 | 6.64 Million USD | -54.23% |
| 2016 Q2 | 14.51 Million USD | 27.2% |
| 2016 Q4 | 6.59 Million USD | -0.66% |
| 2016 Q1 | 11.4 Million USD | -14.2% |
| 2015 Q1 | 8.19 Million USD | 42.14% |
| 2015 FY | 13.29 Million USD | 130.69% |
| 2015 Q4 | 13.29 Million USD | 37.5% |
| 2015 Q3 | 9.67 Million USD | 11.79% |
| 2015 Q2 | 8.65 Million USD | 5.58% |
| 2014 Q2 | 13.07 Million USD | 226.39% |
| 2014 FY | 5.76 Million USD | 386.32% |
| 2014 Q4 | 5.76 Million USD | -46.97% |
| 2014 Q1 | 4 Million USD | 238.05% |
| 2014 Q3 | 10.86 Million USD | -16.89% |
| 2013 Q3 | 1.41 Million USD | 5.87% |
| 2013 Q1 | 1.42 Million USD | 29.38% |
| 2013 Q4 | 1.18 Million USD | -16.26% |
| 2013 FY | 1.18 Million USD | 7.33% |
| 2013 Q2 | 1.33 Million USD | -6.42% |
| 2012 Q1 | 873.9 Thousand USD | -55.55% |
| 2012 Q2 | 652.03 Thousand USD | -25.39% |
| 2012 Q3 | 684.81 Thousand USD | 5.03% |
| 2012 Q4 | 1.1 Million USD | 61.27% |
| 2012 FY | 1.1 Million USD | -43.83% |
| 2011 Q4 | 1.96 Million USD | -26.72% |
| 2011 Q1 | 1.1 Million USD | 51.42% |
| 2011 Q3 | 2.68 Million USD | 83.07% |
| 2011 Q2 | 1.46 Million USD | 33.01% |
| 2011 FY | 1.96 Million USD | 170.2% |
| 2010 Q1 | 133.51 Thousand USD | -54.92% |
| 2010 FY | 727.59 Thousand USD | 145.67% |
| 2010 Q3 | 825.52 Thousand USD | 179.16% |
| 2010 Q4 | 727.59 Thousand USD | -11.86% |
| 2010 Q2 | 295.71 Thousand USD | 121.49% |
| 2009 Q2 | 52.62 Thousand USD | 30.34% |
| 2009 FY | 296.17 Thousand USD | 110.3% |
| 2009 Q4 | 296.17 Thousand USD | 629.61% |
| 2009 Q3 | 40.59 Thousand USD | -22.86% |
| 2009 Q1 | 40.37 Thousand USD | -71.33% |
| 2008 Q1 | 5254.06 USD | -65.88% |
| 2008 Q2 | 60.05 Thousand USD | 1043.0% |
| 2008 Q3 | 144.59 Thousand USD | 140.77% |
| 2008 FY | 140.83 Thousand USD | 814.57% |
| 2008 Q4 | 140.83 Thousand USD | -2.6% |
| 2007 Q4 | 15.39 Thousand USD | 0.0% |
| 2007 FY | 15.39 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|